52 related articles for article (PubMed ID: 18801084)
1. Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California.
Befano B; Wentzensen N; Lorey T; Poitras N; Cheung LC; Schiffman M; Clarke MA; Cohen C; Kinney W; Locke A; Castle PE
Gynecol Oncol; 2024 May; 184():89-95. PubMed ID: 38301311
[TBL] [Abstract][Full Text] [Related]
2. Distribution of human papilloma virus genotype prevalence in invasive cervical carcinomas and precancerous lesions in the Yangtze River Delta area, China.
Wang H; Cheng X; Ye J; Xu X; Hong Y; Sui L; You Z; Xie X
BMC Cancer; 2018 Apr; 18(1):487. PubMed ID: 29703167
[TBL] [Abstract][Full Text] [Related]
3. Prevalence characteristics of high-risk human papillomaviruses in women living in Shanghai with cervical precancerous lesions and cancer.
Gu Y; Ma C; Zou J; Zhu Y; Yang R; Xu Y; Zhang Y
Oncotarget; 2016 Apr; 7(17):24656-63. PubMed ID: 27013587
[TBL] [Abstract][Full Text] [Related]
4. Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide.
Chen AA; Gheit T; Franceschi S; Tommasino M; Clifford GM;
J Virol; 2015 Oct; 89(20):10680-7. PubMed ID: 26269181
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and genotype distribution of human papillomavirus infection among women in northeastern Guangdong Province of China.
Zhao P; Liu S; Zhong Z; Hou J; Lin L; Weng R; Su L; Lei N; Hou T; Yang H
BMC Infect Dis; 2018 May; 18(1):204. PubMed ID: 29724192
[TBL] [Abstract][Full Text] [Related]
6. Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013.
van der Horst J; Siebers AG; Bulten J; Massuger LF; de Kok IM
Cancer Med; 2017 Feb; 6(2):416-423. PubMed ID: 28102052
[TBL] [Abstract][Full Text] [Related]
7. Human Papillomavirus-Induced Chromosomal Instability and Aneuploidy in Squamous Cell Cancers.
Mallick S; Choi Y; Taylor AM; Cosper PF
Viruses; 2024 Mar; 16(4):. PubMed ID: 38675844
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma levels of adipokines and inflammatory markers in older women with persistent HPV infection.
Baker R; Dauner JG; Rodriguez AC; Williams MC; Kemp TJ; Hildesheim A; Pinto LA
Cytokine; 2011 Mar; 53(3):282-5. PubMed ID: 21167737
[TBL] [Abstract][Full Text] [Related]
9. HPV-positive cervical squamous cell carcinoma metastasis to the breast, mimicking primary tumor.
de Oliveira-Junior I; Barbin FF; Watanabe AHU; Dos Reis R; da Costa Vieira RA
Breast Dis; 2022; 41(1):407-411. PubMed ID: 36502298
[TBL] [Abstract][Full Text] [Related]
10. Infection by High-Risk Human Papillomaviruses, Epithelial-to-Mesenchymal Transition and Squamous Pre-Malignant or Malignant Lesions of the Uterine Cervix: A Series of Chained Events?
Barillari G; Bei R; Manzari V; Modesti A
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948338
[TBL] [Abstract][Full Text] [Related]
11. Overview of microarray analysis of gene expression and its applications to cervical cancer investigation.
Chao A; Wang TH; Lai CH
Taiwan J Obstet Gynecol; 2007 Dec; 46(4):363-73. PubMed ID: 18182341
[TBL] [Abstract][Full Text] [Related]
12. The HPV Cellular Transactivator Brn-3a Can Be Used to Predict Cervical Adenocarcinoma and Squamous Carcinoma Precancer Lesions in the Developed and Developing Worlds.
Ndisang D; Lorenzato F; Sindos M; Khan A; Singer A; Latchman DS
Obstet Gynecol Int; 2009; 2009():359457. PubMed ID: 20224757
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of human papillomavirus genotypes and relative risk of cervical cancer in China: a systematic review and meta-analysis.
Xu HH; Wang K; Feng XJ; Dong SS; Lin A; Zheng LZ; Yan WH
Oncotarget; 2018 Mar; 9(20):15386-15397. PubMed ID: 29632652
[TBL] [Abstract][Full Text] [Related]
14. High expression of ezrin predicts poor prognosis in uterine cervical cancer.
Kong J; Li Y; Liu S; Jin H; Shang Y; Quan C; Li Y; Lin Z
BMC Cancer; 2013 Nov; 13():520. PubMed ID: 24182314
[TBL] [Abstract][Full Text] [Related]
15. The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China.
Wang S; Wei H; Wang N; Zhang S; Zhang Y; Ruan Q; Jiang W; Xiao Q; Luan X; Qian X; Zhang L; Gao X; Sun X
BMC Cancer; 2012 May; 12():160. PubMed ID: 22548873
[TBL] [Abstract][Full Text] [Related]
16. Development of a bead-based multiplex genotyping method for diagnostic characterization of HPV infection.
Chung MY; Kim YW; Bae SM; Kwon EH; Chaturvedi PK; Battogtokh G; Ahn WS
PLoS One; 2012; 7(2):e32259. PubMed ID: 22393393
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 16 variant analysis of E6, E7, and L1 [corrected] genes and long control region in [corrected] cervical carcinomas in patients in northeast China.
Shang Q; Wang Y; Fang Y; Wei L; Chen S; Sun Y; Li B; Zhang F; Gu H
J Clin Microbiol; 2011 Jul; 49(7):2656-63. PubMed ID: 21593270
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus infection in Beijing, People's Republic of China: a population-based study.
Zhao R; Zhang WY; Wu MH; Zhang SW; Pan J; Zhu L; Zhang YP; Li H; Gu YS; Liu XZ
Br J Cancer; 2009 Nov; 101(9):1635-40. PubMed ID: 19862002
[TBL] [Abstract][Full Text] [Related]
19. Distribution of HPV genotypes in uterine cervical lesions in Yanbian, northern China.
Zhao Y; Lin H; Shen D; Xuan Y; Lin Z
Pathol Int; 2008 Oct; 58(10):643-7. PubMed ID: 18801084
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]